Bulletin of Semashko National Research Institute of Public HealthBulletin of Semashko National Research Institute of Public Health2415-84102415-8429FSSBI «N.A. Semashko National Research Institute of Public Health»276810.25742/NRIPH.2023.03.003Обзорная статьяRosacea in international practice: relationship with somatic pathology of patients, features of cosmetological careSadykovaRomina N.sadykovaromina23@gmail.comhttps://orcid.org/0000-0003-1771-7537PlutnickiAndrey N.mbufmbc@mail.ruhttps://orcid.org/0000-0002-2933-267XMingazovRustem N.mrn85@mail.ruhttps://orcid.org/0000-0003-3070-0967Biomedical University of Innovation and Continuing Education of the State Scientific Center of the Russian Federation — A.I.Burnazyan Federal Medical Biophysical Center of the Federal Medical Biological Agency of RussiaN. A. Semashko National Research Institute of Public HealthResearch Institute for Healthcare and Medical Management of Moscow Healthcare Department26052023305052025Copyright © 2025,2025<p>The article provides an analysis of the scientific literature, showing that modern research is mainly focused on the role of immunity and microorganisms in the pathogenesis of rosacea. To elucidate the common pathogenetic mechanisms and genetic factors between rosacea and skin cancer, studies in various populations with detailed clinical data, genetic analysis and a longer follow-up period are relevant. Assessment of the quality of life of patients with rosacea is of great interest for clinical practice. It is emphasized that there is an urgent need for global research to develop a modern comprehensive treatment for rosacea, and this pathology, as a chronic inflammatory skin disease, requires active treatment during exacerbations and preventive strategies to limit relapses.</p>rosaceacomorbid somatic diseaseschronic inflammatory skin diseaseskin cancertreatment during an exacerbationpreventive strategies, reviewрозацеасопутствующие соматические заболеванияхроническое воспалительное заболевание кожирак кожилечение во время обостренияпревентивные стратегииобзор1.Zhang J., Yan Y., Jiang P., Liu Z., Liu Y., Liu Y., Wang X., Li M., Xu Y. Association between rosacea and cardiovascular disease: A systematic review and meta-analysis. J Cosmet Dermatol. 2021;20(9):2715—2722. doi: 10.1111/jocd.13884.2.3.Chang H.C., Huang Y.C., Lien Y.J., Chang Y.S. Association of rosacea with depression and anxiety: A systematic review and meta-analysis. J Affect Disord. 2022;(299):239—245. doi: 10.1016/j.jad.2021.12.008.4.5.Incel Uysal P., Akdogan N., Hayran Y., Oktem A., Yalcin B. Rosacea associated with increased risk of generalized anxiety disorder: a case-control study of prevalence and risk of anxiety in patients with rosacea. An Bras Dermatol. 2019;94(6):704—709. doi: 10.1016/j.abd.2019.03.002.6.7.Tsai T.Y., Chiang Y.Y., Huang Y.C. Cardiovascular Risk and Comorbidities in Patients with Rosacea: A Systematic Review and Meta-analysis. Acta Derm Venereol. 2020;100(17). doi: 10.2340/00015555—3668.8.9.Cho S.I., Lee H., Cho S. Risk of Skin Cancer and Actinic Keratosis in Patients with Rosacea: A Nationwide Population-based Cohort Study. Acta Derm Venereol. 2022;102. doi: 10.2340/actadv.v102.2563.10.11.Wienholtz N.K.F., Christensen C.E., Zhang D.G., Rechnagel A.A., Byrnel H.V.S., Haugaard J.H., Ashin M., Thyssen J.P., Egeberg A. Clinical characteristics of combined rosacea and migraine. Front Med (Lausanne). 2022;(9). doi: 10.3389/fmed.2022.1026447.12.13.Chung B.Y., Kim H.O., Park C.W., Yang N.G., Kim J.Y., Eun Y.S., Chung E.H., Lee S.Y., Park Y.L., Lee S.H., Heo N.H., Shin M.J., Kim J.E. Relationships of Serum Homocysteine, Vitamin B12, and Folic Acid Levels with Papulopustular Rosacea Severity: A Case-Control Study. Biomed Res Int. 2022; 2022. doi: 10.1155/2022/5479626.14.15.Forton F.M.N.The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea. Dermatol Ther (Heidelb). 2020;10(6):1229—1253. doi: 10.1007/s13555-020-00458-9.16.17.FortonF .M.N.Rosacea, an infectious disease: why rosacea with papulopustules should be considered a demodicosis. A narrative review. J Eur Acad Dermatol Venereol. 2022;36(7):987—1002. doi: 10.1111/jdv.18049.18.19.Nobeyama Y., Aihara Y., Asahina A. Characteristics of Rosacea and Similar Diseases in Patients Wearing Face Masks. Skin Appendage Disord. 2022;8(6):462—468. doi: 10.1159/000525024.20.21.Yang F., Zhang Q., Song D., Liu X., Wang L., Jiang X. A Cross-Sectional Study on the Relationship Between Rosacea Severity and Quality of Life or Psychological State. Clin Cosmet Investig Dermatol. 2022;(15):2807—2816. doi: 10.2147/CCID.S390921.22.23.Kang C.N., Shah M., Tan J. Rosacea: An Update in Diagnosis, Classification and Management. Skin Therapy Lett. 2021;26(4):1—8.24.25.Nowicka D., Chilicka K., Dzieńdziora-Urbińska I., Szyguła R. Skincare in Rosacea from the Cosmetologist's Perspective: A Narrative Review. J Clin Med. 2022;12(1). doi: 10.3390/jcm12010115.26.27.Hu X.M., Li Z.X., Zhang D.Y., Yang Y.C., Zheng S.Y., Zhang Q., Wan X.X., Li J., Yang R.H., Xiong K. Current research and clinical trends in rosacea pathogenesis. Heliyon. 2022;8(10). doi: 10.1016/j.heliyon.2022.e10874.28.29.Zier lS., Guertler A., Hildebrand J.A., Clanner-Engelshofen B.M., French L.E., Reinholz M. A comprehensive epidemiological study of rosacea in Germany. Eur J Dermatol. 2021;31(6):744—751. doi: 10.1684/ejd.2021.4165.30.31.van Zuuren E.J., Arents B.W.M., van der Linden M.M.D., Vermeulen S., Fedorowicz Z., Tan J. Rosacea: New Concepts in Classification and Treatment. Am J Clin Dermatol. 2021;22(4):457—465. doi: 10.1007/s40257-021-00595-7.32.33.Miyachi Y., Yamasaki K., Fujita T., Fujii C. Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle-controlled, phase 3 study. J Dermatol. 2022;49(3):330—340. doi: 10.1111/1346—8138.16254.34.35.Del Rosso J.Q., York J.P., Bhatia N. Effective Treatment of Inflammatory Lesions of Rosacea with Subantibiotic Dose Doxycycline Irrespective of Patient Weight or Baseline Lesion Count Severity. J Clin Aesthet Dermatol. 2022;15(11):69—74.36.37.van Zuuren E.J., Fedorowicz Z., Tan J., van der Linden M.M.D., Arents B.W.M., Carter B., CharlandL. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. Br J Dermatol. 2019;181(1):65—79. doi: 10.1111/bjd.17590.38.39.Sarkar R., Podder I., JagadeesanS. Rosacea in skin of color: A comprehensive review. Indian J Dermatol Venereol Leprol. 2020;86(6):611—621. doi: 10.4103/ijdvl.IJDVL_769_19.40.41.Maliyar K., Abdulla S.J. Dermatology: how to manage rosacea in skin of colour. Drugs Context. 2022;(11):2021-11-1. doi: 10.7573/dic.2021—11.